Skip to main content
. 2019 Jan 31;20(2):97–102. doi: 10.5152/TurkThoracJ.2018.18055

Table 1.

Demographics of the study population

ACO (n=40) (11.8%) Asthma (n=298) (88.2%) p
Age (years), mean±SD 63.78±10.23 53.86±13.04 0.0011
Gender, n (%)
 Female 27 (67.5%) 64 (21.5%) 0.0012
 Male 13 (32.5%) 234 (78.5%)
Mean age of asthma onset, mean±SD 48.73±13.01 38.81±13.42 0.0011
Smoking pack-years, median (min-max) 22.5 (0–50) 0 (0–100) 0.0011
Asthma duration (years), mean±SD 15±7.88 15.07±10.73 0.4533
Treatment ICS dose, n (%)
 Low-medium dose 19 (47.5%) 208 (69.8%) 0.0081
 High dose 21 (52.5%) 90 (30.2%)
Hospitalizations, median (min-max) 0 (0–5) 0 (0–5) 0.7883
Attacks, median (min-max) 0 (0–3.75) 0 (0–3.33) 0.9523
1

Independent samples t-test

2

Continuity correction chi-square test

3

Mann-Whitney U

ACO: asthma-COPD overlap; ICS: inhaled corticosteroids; SD: standard deviation